HealthThe Next Webabout 2 hours ago
AstraZeneca and Oracle partner on AI trials
2 min read
AstraZeneca and Oracle announced a non-binding term sheet to use AI and patient health data for finding drug trial participants. The initial program runs in Abu Dhabi with M42 to treat high blood pressure, with later projects planned for the US, Middle East, and Europe covering cancer, heart, kidney, lung, immune, and rare diseases.
Level
Hype check
Tap to vote and see what everyone thinks.
In this storyOracle
